Podcasts about Johns Hopkins

In his weekly clinical update, Dr. Griffin with Vincent Racaniello are distressed by the continuing government shutdown, first locally acquired chikungunya virus infection, President Trump's suggestion for removing aluminum from vaccines, H5N1 isolation from backyard birds and turkey farms, and the suggestion of establishing an alternative to the CDC's MMWR and asymptomatic measles infections before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the quarantining in the US due to measles, access to anti-influenza antiviral, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, if colchicine is effective for long COVID, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode New York health officials confirm state's first locally acquired case of chikungunya virus (AP News) Trump Rattles Vaccine Experts Over Aluminum (NY Times) Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood (Annals of Internal Medicine) Three large turkey farms in Minnesota hit with H5N1 avian flu (CIDRAP) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Jeffrey Lee McLean (California.No) California mpox cases raise concerns. But health officials say the risk remains low (AP News) ‘Alternative' to CDC's Flagship Journal in the Works (MEDPAGE TODAY) Measles without rash during acute febrile illness surveillance in Tanzania, 2023-2024 (CID) Frustration grows amid measles outbreak quarantines across several states (NBC News) More Than 100 Cases of Measles Reported in Utah and Arizona (NY Times) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine recommendations from NYP (jpg) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) American Academy of Pediatrics Flu and Children (CDC: Influenza (flu)) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) Roche to sell flu pill for $50 to cash-paying US patients (Reuters) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines (Cochrane Library) Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Acute Respiratory Illness in Older Adults (CID) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Effectiveness of Colchicine for the Treatment of Long COVID(JAMA Internal Medicine) Reaching out to US house representative Letters read on TWiV 1264 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Dr. John Gartner joins the Beast's Joanna Coles to assess the unraveling of Donald Trump's mind. The clinical psychologist and former Johns Hopkins professor, who warned early about Trump's “malignant narcissism,” now says the president shows clear signs of cognitive decline, comparing his confusion and grandiosity to dictators in their final stages. Coles presses Gartner on whether Trump's dementia makes him more dangerous or simply more delusional, and what that means for the remainder of Trump's second term and beyond. Is America being led by a man losing touch with reality, or is Trump still cunning enough to conceal his growing symptoms? Hosted on Acast. See acast.com/privacy for more information.

Key PointsDeborah's symptoms began in 2013 with weakness in her legs and lower extremities, initially misdiagnosed by her family doctor who recommended exercise and weight loss for two years.A CAT scan revealed the AVM was located in the very pit of Deborah's spinal cord inside the cord itself, requiring immediate hospitalization due to risk of catastrophic paralysis.Deborah underwent her first eight and a half hour neurosurgery while positioned face-down with electrodes monitoring her body, but the surgeon was unable to remove all the problematic veins.Following the incomplete first surgery, Deborah was told she would need additional operations and that her condition would worsen without further intervention.After four years of deterioration, Deborah underwent a second eight-hour operation at Johns Hopkins where surgeons successfully removed the remaining vein.Prescription medications including opioids, tramadol, oxycodone, gabapentin, and baclofen provided minimal pain relief while causing significant side effects and dependency.Megan Hall, working in film in Los Angeles, began researching cannabis health benefits as an alternative to help her mother avoid opioid dependency and early death.Al Marenton of My Fit Life offered to help Deborah after meeting Megan at a cannabis event in 2016, creating a CBD-dominant RSO with no THC to avoid medical benefit complications.Initial CBD usage was inconsistent due to Deborah's concerns about saving the product, until Megan and Al established a regular dosing regimen.Deborah successfully discontinued tramadol while continuing CBD treatment, experiencing complete elimination of her thoracic back pain and improved mobility including riding a three-wheel bike.Medical professionals initially discouraged CBD use due to insurance and testing concerns, but Deborah's pain management doctor recently expressed approval of her CBD-only pain management approach.Deborah now lives independently using only CBD for pain management, drives, and uses a walker for mobility assistance while remaining completely free of opioid medications. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee begin a two-part forensic review of the 2011 death of Ellen Greenberg, a young woman found with more than twenty stab wounds in her Philadelphia apartment. Despite the severity and location of her injuries, Ellen’s death was ruled a suicide not once but twice. In part one, Dr. Priya walks listeners through the science of sharp-force injuries, defines key forensic terminology, and explains why certain wound patterns, especially those to the back of the head and neck, raise significant questions about how this case was ever closed. Highlights (0:00) Welcome to Pathology with Dr. Priya: A Zone 7 series—Sheryl McCollum and Dr. Priya introduce the Ellen Greenberg case and outline the official findings (2:00) Dr. Priya defines sharp-force injuries and explains the difference between stab and cutting wounds (6:45) Identifying single-edged versus double-edged blades and how wound shape reveals the type of weapon (8:00) Understanding defensive wounds and what their presence means (10:30) The classification of cause and manner of death and why Ellen Greenberg’s case remains controversial (13:45) How and why medical examiners revisit cases when new information or legal action arises (16:30) Reviewing Ellen’s autopsy and toxicology results (18:45) Why stab wounds to the back of the head and neck are nearly impossible to self-inflict and what that reveals about this case About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, NSA cases, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.comTwitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.comTwitter/X: @ColdCaseTipsFacebook: @sheryl.mccollumInstagram: @officialzone7podcast

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” as we welcomed Rebecca McLaughlin to answer questions about how Jesus' love addresses homophobia and sexism. Rebecca holds a PhD in Renaissance Literature from Cambridge University and a theology degree from Oak Hill College in London. She has also written the book, “Confronting Christianity: 12 Hard Questions for the World’s Largest Religion,” which was named Book of the Year by Christianity Today. Then we had Dr. Bill West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” We also had Dr. Mark Jobe join us to talk about “Founders Week”, a week of Bible teaching and a time of worship for the Moody Bible Institute (MBI). Dr. Jobe is the 10th President of MBI and the founding Pastor of New Life Community Church in Chicago, as well as the founder of New Life Centers. He is also a graduate of Moody Theological Seminary and the host of the radio show "Bold Steps, " which airs every weekday at 1 pm on 90.1 FM Moody Radio. You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Rebecca McLaughlin Interview [03:55] Dr. Bill West Interview [51:35 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

In his weekly clinical update, Dr. Griffin with Vincent Racaniello are dismayed by the government shutdown, the firings at the CDC including EIS agents, H5N1 isolation from backyard birds and its stability in raw milk and cheese, before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the quarantining of college students in the US due to measles, Japan's declaration of a national influenza outbreak, effectiveness of the influenza and COVID vaccines, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, results from PLATCOV studies- still no antiviral activity attributed to ivermectin, where to go for answers to your long COVID questions, long COVID in pediatrics, patient reported outcomes from the STOP-PASC clinical trial, contacting your federal government representative to stop the assault on science and biomedical research and the listener reminder that measles vaccine in those with interferonopathy may result in severe adverse affects. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Trump Administration Lays Off Dozens of C.D.C. Officials (NY Times) CDC walks back hundreds of firings as US shutdown persists (Yahoo News/ Reuters) CDC battered by government shutdown firings, while some are rescinded (STAT 10) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Flurry of H5N1 activity noted in commercial poultry, wild birds(CIDRAP) H5N1 influenza virus stability and transmission risk in raw milk and cheese(Nature Medicine) Hundreds of U.S. students quarantined amid measles outbreaks (NBC News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Japan sees early flu activity, with school closures(CIDRAP) Japan Declares Nationwide Flu Outbreak Following Early Surge in Cases (insightscare) ACIP Recommendations Summary (CDC: Influenza) American Academy of Pediatrics Flu and Children (CDC: Influenza (flu)) Effectiveness of influenza vaccination to prevent severe disease (CMI: Clinical Microbiology and Infection) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines (Cochrane Library) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccination in South Korean Adolescents (The Pediatric Infectious Disease Journal) Trump gets Covid vaccine and flu shot during second checkup of the year (NBC News) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)(eLife) Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV) (LANCET: Infectious Diseases) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection (JAMA Internal Medicine) Longitudinal patient-reported outcome trajectories in Long COVID: Findings from the STOP-PASC Clinical Trial (OFID) Reaching out to US house representative Severe Adverse Reaction to Measles Vaccine Due to Homozygous Mutation in the IFNAR2 Gene: A Case Report and Literature Review (Journal of Clinical Immunology) Letters read on TWiV 1262 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode, Dr. T.Y. Alvin Liu, Inaugural Director of the AI Innovation Center at Johns Hopkins Medicine, shares how one of the nation's top academic health systems is pioneering AI implementation, governance, and the future of oculomics. He unpacks the challenges of real-world deployment and why collaboration and rapid iteration are key to success.

In this episode, we sit down with Charlie Pearson, senior offensive tackle at Johns Hopkins University and member of the Allstate AFCA Good Works Team. Charlie helped lead the Blue Jays to a 12-2 record, a Centennial Conference Championship, and a historic trip to the 2024 NCAA Division III Semifinals — all while maintaining a 3.87 GPA as a Public Health major. Recognized as the Centennial Conference Football Scholar-Athlete of the Year, he's the definition of excellence on and off the field. Off the gridiron, Charlie serves as a certified EMT responding to 911 calls in Baltimore, mentors youth through Blue Jays for Baltimore, supports returning citizens through Turnaround Tuesday, and leads fundraising efforts for children's health with HopThon. Join us as we explore how Charlie balances football, academics, and community service — and what it means to be a student-athlete making an impact beyond the game. Follow @hopkinsfootball on social media for more.

Join Lynn Hoffman for this new episode of Music Saved Me with Doctor Tasha Golden. From touring musician to Johns Hopkins scientist - Dr. Tasha Golden’s journey through creative burnout led her to pioneer “arts on prescription” research. She shares how music both broke and remade her, and what science reveals about creativity’s power to heal. A raw, hopeful conversation about transformation, resilience, and why your doctor might soon prescribe you a concert. Support the show: https://takinawalk.com/See omnystudio.com/listener for privacy information.

Join Lynn Hoffman for this new episode of Music Saved Me with Doctor Tasha Golden. From touring musician to Johns Hopkins scientist - Dr. Tasha Golden’s journey through creative burnout led her to pioneer “arts on prescription” research. She shares how music both broke and remade her, and what science reveals about creativity’s power to heal. A raw, hopeful conversation about transformation, resilience, and why your doctor might soon prescribe you a concert. Support the show: https://musicsavedme.net/See omnystudio.com/listener for privacy information.

Reinvention often begins with a single moment that changes how we see our lives and the impact we want to make. Michelle Bockman, CEO of KeraLink International, shares her story and it reminds us what can happen when vision and purpose align.Michelle's story is one of true reinvention. After building a remarkable corporate career across Fortune 100 companies and Silicon Valley startups, she found herself at a crossroads. Around that same time, life threw her an unexpected curveball, she lost the central vision in her right eye due to a rare condition. During her treatment, doctors also discovered cancer in her other eye.What happened next changed everything. While Michelle regained her full 20/20 vision after treatment at Johns Hopkins, the experience opened her eyes (literally and figuratively) to a new calling, leading KeraLink International, a nonprofit focused on ending preventable blindness around the world.Michelle has completely reimagined what a modern nonprofit can be. She's built an ecosystem that includes:Community Programs that bring eye screenings and care to underserved areas.KeraX Venture Studio, developing affordable eye-care technologies that can be used anywhere in the world.KeraLink.com, an eyewear brand where 100% of the profits go right back into funding care.One of my favorite parts of our conversation was hearing how they're training women health workers in India who go door-to-door to help families get care. These women are finding new confidence, independence, and purpose creating ripple effects that go far beyond vision care.“When vision meets purpose, everything becomes clear.” — Michelle BockmanMichelle's story is a powerful reminder that reinvention is about embracing unexpected opportunities and being open to possibilities.Action Step: Take a quiet moment this week to ask yourself: What part of my story is ready to be seen in a new light? Sometimes clarity begins when we give ourselves permission to look again.About Michelle Bockman:Michelle Bockman is President & CEO of KeraLink International, a nonprofit focused on reducing corneal blindness globally by expanding eye care accessibility. With 25+ years of leadership at Fortune 100s and Silicon Valley startups, she brings strategic vision and a passion for innovation to her mission-driven role.Find out more:https://www.linkedin.com/in/michellebockman/https://keralink.orgLinkedIn: https://www.linkedin.com/company/keralink-international/YouTube: @KeraLinkInternationalInstagram: @keralink_internationalFacebook: https://www.facebook.com/KeraLinkIntlKeep shining your light bright. The world needs you.Connect with Natalie BenamouNatalie Benamou is Founder of HerCsuite®, the first professional women's network infusing AI into courses, masterminds for women leaders, board directors and entrepreneurs. She also serves as President and CEO of HER HEALTHX, a nonprofit bridging the care communication gap and improving health outcomes for women.

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” with discussions about evolution and intelligent design. Dr. Casey Luskin joined us to discuss his faith story and his experience as a scientist who advocates for intelligent design. Dr. Luskin is a scientist and an attorney with graduate degrees in science and law. He has been a California-licensed attorney since 2005, practicing in the area of evolution-education in public schools and defending academic freedom for scientists who face discrimination because they support intelligent design. He also co-founded the Intelligent Design and Evolution Awareness (IDEA) Center, a nonprofit organization that helps students on college and high school campuses. Then we had Dr. William West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” Then we had Dr. Fazale Rana, also known as “Dr. Fuz,” join us to share his story and discuss some advancements in biotechnology and their impact on transhumanism. Dr. Fuz is the President, CEO, and Senior Scholar at Reasons to Believe. He also holds a PhD in chemistry with a focus on biochemistry from the University of Ohio. He also wrote the book, “The Cell’s Design (Reasons to Believe): How Chemistry Reveals the Creator’s Artistry.” You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Dr. Casey Luskin Interview [03:37 ] Dr. Fazale Rana “Dr. Fuz” Interview [37:39 ] Dr. William West Interview [58:53 ] Caller Response (You were a Skeptic of Science and Now You're a Believer) [01:08:38 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Host Jason Blitman talks with Megha Majumdar about her acclaimed second novel, A Guardian and a Thief—recently nominated for the Kirkus Prize and shortlisted for the National Book Award.Conversation highlights include:

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  http://edenlabs.com You'll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you're curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what's possible when we reconnect the brain, body, and spirit.  

In this episode of SaaS Fuel, host Jeff Mains welcomes Harish Chandramowli, CEO of Flare, to unpack the evolution of ERP systems in the age of AI—specifically for fashion brands and SMBs.Harish shares insights from his unique career path, spanning cybersecurity at Johns Hopkins, engineering at Bloomberg and MongoDB, to tackling unstructured data and workflow automation for modern retailers. The conversation dives deep into the intersection of technology, scalable team building, and founder-led sales—along with candid lessons learned while bootstrapping, selling, and leading distributed teams across the globe.Key Takeaways00:00 Tech Innovation and People-First Leadership06:18 "SMB Market Gap: Custom ERP Needed"07:29 Flexible ERP Solutions with MongoDB12:34 AI Streamlines ERP Communication15:55 Increase Sales with Incomplete Products18:40 "Benefits of Technical Founders"23:02 Cultural Sensitivity in Global Teams25:41 Delegation as a Learning Opportunity29:43 "Team Growth and Skill Challenges"32:37 AI-Driven Business Insights36:22 Optimizing Workflow with AI Automation39:58 Future Growth: Strategies & Insights40:49 "SaaS Fuel Podcast Overview"Tweetable QuotesThe Power of Flexible Data: "One of the things that I learned in MongoDB is flexible data has so much power. It's so much easier to help people understand their business without having to pay." — Harish Chandramowli AI Revolutionizing Supply Chain Communication: "AI can learn. Your emails say that, hey, you got an email from your factory saying that things are getting delivered and AI can parse your attachment, fill in those data, you just need to verify and approve it and the workflow is done." — Harish Chandramowli Viral Topic: The Importance of Cultural Understanding in Global Teams: "Understanding each other's culture goes a long way in people feeling close to you." — Harish Chandramowli SaaS Leadership LessonsUnderstand Before You Automate: Deeply map out a customer's workflow before implementing automation. AI is most powerful when embedded where the real pain is.Founders Must Stay Hands-On: Engaged, founder-led sales and customer interactions are critical in the early stages—don't retreat into just building.Hire for Culture & Autonomy: Successful distributed teams thrive on self-motivation, global empathy, and transparent communication.Don't Fear Delegation: Letting your team handle challenges increases their growth and the company's overall resilience.Sales and Engineering Need Real Collaboration: Break down silos by involving engineers in sales calls and non-technical staff in planning meetings.Contextualize AI's Role for Customers: When selling AI-driven solutions, focus on the concrete problem solved, not the flashy technology. Realism and transparency build trust.Guest Resourcess.c.harish@gmail.comharish@flairesoftware.com https://www.flairesoftware.com/ https://www.linkedin.com/in/scharish/Episode SponsorThe Captain's KeysSmall Fish, Big Pond –

Today, on Karl and Crew, we continued our weekly theme of “Tough Questions for Christians” with discussions about evolution and intelligent design. Dr. Casey Luskin joined us to discuss his faith story and his experience as a scientist who advocates for intelligent design. Dr. Luskin is a scientist and an attorney with graduate degrees in science and law. He has been a California-licensed attorney since 2005, practicing in the area of evolution-education in public schools and defending academic freedom for scientists who face discrimination because they support intelligent design. He also co-founded the Intelligent Design and Evolution Awareness (IDEA) Center, a nonprofit organization that helps students on college and high school campuses. Then we had Dr. William West join us to discuss the intersection and contradictions between faith and science. Dr. West, a Harvard and Johns Hopkins-trained oncologist and researcher, has advanced cancer care and research for over three decades. He has lectured for more than forty years on the myth of science and faith being at odds, believing they support one another and that science reveals God. He has also written a book called “Sacred Science: Understanding Divine Creation.” Then we had Dr. Fazale Rana, also known as “Dr. Fuz,” join us to share his story and discuss some advancements in biotechnology and their impact on transhumanism. Dr. Fuz is the President, CEO, and Senior Scholar at Reasons to Believe. He also holds a PhD in chemistry with a focus on biochemistry from the University of Ohio. He also wrote the book, “The Cell’s Design (Reasons to Believe): How Chemistry Reveals the Creator’s Artistry.” You can hear the highlights of today's program on the Karl and Crew Showcast. If you're looking to listen to a particular segment from the show, look at the following time stamps: Dr. Casey Luskin Interview [03:37 ] Dr. Fazale Rana “Dr. Fuz” Interview [37:39 ] Dr. William West Interview [58:53 ] Caller Response (You were a Skeptic of Science and Now You're a Believer) [01:08:38 ] Karl and Crew airs live weekday mornings from 5-9 a.m. Central Time. Click this link for ways to listen in your area! https://www.moodyradio.org/ways-to-listen/Donate to Moody Radio: http://moodyradio.org/donateto/morningshowSee omnystudio.com/listener for privacy information.

Before a body is ever opened, a medical examiner must consider what dangers might be waiting inside: fentanyl, tuberculosis or even a hidden needle. This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee share stories from their recent visit to Lake Tobias Wildlife Park. There, they took part in Wildlife CSI training, a hands-on blend of forensic education and animal encounters, including time with Chester, a baby kangaroo who quickly won everyone over. From there, the conversation shifts to the serious risks medical examiners face every day. From bloodborne pathogens and drug exposure to unstable death scenes and unpredictable infections, Dr. Priya offers a closer look at the hidden hazards behind every autopsy. Highlights (0:00) Welcome to Pathology with Dr. Priya: A Zone 7 series—Sheryl and Dr. Priya open the episode with highlights from the Wildlife CSI training at Lake Tobias Wildlife Park (3:15) Embracing lifelong learning, from seasoned investigators to students in the field (4:45 Honoring Dr. Jane Goodall and recognizing how wildlife crime intersects with forensic science (6:30) The hidden dangers of autopsy work: COVID, drug exposure, and unknown infections (8:30) Safety in the morgue: scalpel slips, needle sticks, and the rise of pandemic-era protocols (12:30) Fentanyl, MRSA, TB, and the health risks involved in cases with limited medical histories or unidentified individuals (17:00) Environmental hazards at the death scene, from fire damage and rough terrain to unpredictable animals (22:15) Morgue myths, pet protection, and why even the smallest details can carry big dangers About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, NSA cases, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.comTwitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.comTwitter/X: @ColdCaseTipsFacebook: @sheryl.mccollumInstagram: @officialzone7podcast

These are the things that make up Division III football this time of year. W's and L's as in wins and losses, X's and O's as in how plays and schemes are drawn up on paper, and 0's and 1's as in the data that is used to determine who will make the playoffs and how they'll be seeded, in the NCAA Power Index. We got the first look at the NCAA's version of the data in the NPI this week, and no surprise to anyone here that the data fully passed inspection and is exactly the same as what we've seen on D3datacast -- that's the link on our home page menu, for your reference. Of course, there were some great games to run down this week, such as how the folks at Johns Hopkins put together a third- and fourth-quarter rally to get past Carnegie Mellon. We talk about how the game turned, what can be learned, how the teams can grow from here. Hardin-Simmons/Mary Hardin-Baylor and Berry-Trinity (Texas) were big games that ended up not being close. What's up with UMHB? And we also chat with Tony Kunczewski, the head coach at Berry, about his team's big day and their win in our Fast 5 segment. And yes, there were upsets in the WIAC. Or were there? What really constitutes an upset in WIAC games these days? Co-hosts Patrick Coleman and Greg Thomas talk it through.  Patrick and Greg hand out game balls, spotlight the unusual stats of the week, Logan Hansen talks about which teams have the best chance of getting a top-eight seed and protected home field in the playoffs, we go around each region for even more stories and much more in this edition of the D3football.com Around the Nation podcast.

Imagine an engineer who's gone from writing code to building a venture-backed startup—now creating AI-powered tools tailored for fashion brands in New York. That's Harish Chandramowli, Co-Founder of Flaire. His journey is a compelling example of the kind of leadership, innovation, and resilience we highlight on the Breakfast Leadership Show. With a twelve-year engineering career at organizations like MongoDB, Bloomberg, and Johns Hopkins, Harish made the leap into entrepreneurship by co-founding Flaire—an ERP platform that fuses artificial intelligence with user-centered design for retail. What makes Harish's story stand out is his ability to blend deep technical expertise with the gritty, hands-on realities of scaling a business. Whether he's designing smarter code-review workflows (like Greptile, which dramatically reduces dev feedback cycles) or jumping into client sales conversations, Harish brings a unique perspective. He's learned firsthand how to build high-performing remote teams rooted in trust, and how small, strategic process bets can drive sustainable growth. LinkedIn: https://www.linkedin.com/in/scharish/ Website: https://Flairesoftware.com This episode's partner is MRPeasy.  Link to sign up:  https://try.mrpeasy.com/rzhgcr9jcov5   The AI-powered MRP software for small manufacturers Ideal for companies with 10 - 200 employees MRPeasy is a seriously powerful yet easy-to-use manufacturing software. It gives you everything you need to manage your manufacturing and distribution.  

According to a 2024 World Health Organization study, over the last 50 years vaccines have saved over 154 million lives worldwide from over 20 life threatening diseases. As vaccines are facing skepticism, we are here to cut through the noise and lay out the facts as to why staying up-to-date on vaccinations is especially important for kidney patients. This episode is supported by Moderna.  In today's episode we heard from:  Mary Baliker has been a dedicated healthcare advocate for the past 40 years, and is involved in several kidney initiatives regionally, nationally and globally. Mary was diagnosed with a rare kidney disease at the age of nine and since then has undergone hemodialysis and received four kidney transplants. As a result of this life-long journey, Mary cherishes her life and possesses a strong desire to help improve the healthcare experience, health outcomes and quality of life for patients with kidney disease. In addition to publishing multiple peer reviewed articles related to the kidney patient experience, Mary is the author of Maria Never Gives Up, a story written to help children and families facing chronic illnesses. Her book is distributed across transplant and dialysis centers nationwide and is available for purchase online William Werbel, MD, PhD is a transplant infectious diseases physician and scientist at Johns Hopkins focused on optimizing protection against infections in immunocompromised persons. He completed clinical and research fellowship in infectious diseases at Johns Hopkins following MD training at the University of Michigan and internal medicine residency and chief residency at the Northwestern Feinberg School of Medicine. He is the current Associate Director for Epidemiology and Quantitative Sciences in the Johns Hopkins Transplant Research Center and principal investigator of the national Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) cohort study. He receives NIH funding to study the landscape of infections in transplant recipients and evaluate the real-world impact of vaccination using a combination of epidemiological and laboratory approaches. Additional Resources: Vaccines for CKD Patients Vaccine Integrity Project IDSA Immunization Resources Emerging Pathogens of Concern in Immunocompromised Persons (EPOC) Study   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

In his weekly clinical update, Dr. Griffin with Vincent Racaniello chat about Jane Goodall's death and the Nobel prize in Physiology/Medicine for understanding immune system control before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, if 2 doses of the influenza vaccine are better for protection of first season children, if COVID-19 negatively impacts pregnancy and the unborn child, efficacy of long-acting monoclonal antibody against symptomatic COVID-19, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, long COVID in pediatrics, association of COVID-19 with new-onset vascular dementia and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Jane Goodall's legacy: three ways she changed science (Nature) They understood how the immune system is kept in check (The Nobel Prize) Daniel Griffin: The Nobel Prize for Understanding Autoimmune Disease (WNYC: New York Public Radio) Kennedy's Ties to Ally Leading Vaccine Lawsuits Raise Ethical Concerns (NY Times) Ebola outbreak in southern Congo shows signs of containment with no new cases, WHO reports (AP News) Ebola Disease (WHO: African Region) Premature baby dies from measles in Alberta as cases throughout province near 2,000(Global News) DOH Issues Advisory After Measles Detection in City of Oswego Wastewater (Finger lakes dailynew.com) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Influenza-Associated Pediatric Deaths — United States, 2024–25 Influenza Season (CDC: MMWR) ACIP Recommendations Summary (CDC: Influenza) American Academy of Pediatrics Flu and Children (CDC: Influenza (flu)) Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza (JAMA: Open Network) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines(Cochrane Library) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Neonatal outcomes among pregnant women with COVID-19 (BMC Pregnancy and Childbirth) Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19 (CID) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity (CID) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR) (LANCET: Infectious Diseases) Prevalence and duration of clinical symptoms of pediatric long COVID (Frontiers in Pediatrics) COVID-19 infection associated with increased risk of new-onset vascular dementia in adults ≥50 years(NPJ| dementia) Reaching out to US house representative Letters read on TWiV 1260 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

On the heels of being honored at Bronx Lacrosse's annual fundraiser, Chair of the USA Lacrosse Foundation Board and Johns Hopkins alum joins IL's Terry Foy to discuss the many different aspects of the sport that he touches, from Team USA's Olympic aspiration to grassroots development, from being the dad of a '27 who just committed to North Carolina to being a PLL investor and NLL team owner. Check out the wide-ranging conversation with one of lacrosse's most interesting and influential voices.

This quick, hope-filled Saddle Up distills my full conversation with my surgeon, Dr. Elizabeth O'Leary, into practical steps you can take this week. Early detection saves lives. Courage + a simple plan = peace.What You'll LearnWhy early detection changes everythingThe 25-year-old high-risk assessment every woman should know aboutWhat to do if you have dense breasts (better imaging options)Lifestyle levers that actually move the needle (movement, stress, alcohol, steady nutrition)A simple prayer + mindset script to calm anxietyTime-Stamped Guide (approx.)00:00 — Why this episode matters (hope > fear)01:00 — Appointments to make + when to start02:00 — High-risk assessment at 25: what it is, who needs it03:30 — Dense breasts: mammogram + MRI/ultrasound strategy04:30 — Lifestyle that helps: movement, steady nutrition, stress, alcohol06:00 — Mindset + prayer to carry you throughThe Saddle Up Checklist (pick 1–3)Book your mammogram (start at 40; sooner if high-risk).Forward this to a 25–35 year-old you love and nudge a high-risk assessment.Dense breasts? Message your provider about alternating mammogram + MRI based on your risk.Choose one lever: add a 20-minute walk, swap one drink for sparkling water, or add protein + plants to lunch.Write & carry this prayer:“God, I'm placing my health in Your hands. Lead me to the right steps and the right people. Give me courage to act and peace to rest.”Key TakeawaysEarly > easy. Catch it early and treatment is often simpler—and curative.No family history? Still go. ~80% of women diagnosed have no family history.Personalize it. Dense breasts and/or higher risk may mean different imaging.Small habits help. Aim toward ~300 min/week of movement, include strength, keep nutrition steady, reduce alcohol, and prioritize sleep + stress care.Peace is possible. You don't need perfect—just the next faithful step.Favorite Quote“Courage isn't the absence of fear; it's acting with peace anyway.”About Our GuestDr. Elizabeth O'Leary is a breast surgeon and founder of Lady Slipper Breast Center with locations in St. Paul, St. Louis Park, and Edina. Trained at the University of Minnesota and Johns Hopkins, she's passionate about personalized, whole-person care—before, during, and after treatment.https://www.elizabetholearymd.comConnect with Lesalesakoski.comPodcast: Doing Life...

What if the autistic children of today are showing us the next stage of human consciousness, where telepathy, intuition, and deep connection are completely natural?In today's episode, Ashley sits down with Dr. Diane Hennacy Powell, MD, an internationally recognized expert on autism, savant syndrome, and consciousness. Her groundbreaking research has been featured in The Telepathy Tapes, where she explores extraordinary communication abilities among autistic children. A neuroscientist trained at Ohio State and Johns Hopkins, Dr. Powell has devoted her career to understanding the mind's hidden capacities and the bridge between science and spirituality. Together, Ashley and Diane explore how telepathy is not just a phenomenon of gifted savants, but a glimpse into humanity's evolving consciousness.Tune in to Episode 286 of Uncover Your Magic to rediscover your own intuitive potential and see the world through a new lens. You'll hear about the scientific roots of telepathy, how autistic children are teaching us about oneness, and the future of education and consciousness. Plus, Diane shares the fascinating story of her research in India, her encounters with “blue light beings,” and her mission to reunite science with spirit.When we remember that we are all connected beyond words, we unlock a level of communication that transcends time and space — and reconnect with the magic that's always been within us.Episode Takeaways (timestamps)00:04:00 – Diane's early scientific training and first experiences with telepathy00:19:00 – How her medical career led to a psychic encounter that changed everything00:37:00 – The autistic savants who communicate telepathically and what they teach us about consciousness00:53:00 – The mystery of the “blue light beings” and the shift in planetary awareness01:07:00 – The future of education, intuition, and why humanity is ready for a new paradigmResources & LinksConnect with Dr. Diane Hennacy Powell: Website • Twitter/XRecommended Resource: The ESP Enigma – Signed copies available through her websiteLet's Connect!Connect with Ashley: Website • Instagram • FacebookYour Next Move: Subscribe to Uncover Your Magic PodcastShare with a Friend: Simply forward this email, it's that easy or tag them on socialFree Gift: Download your Easy Magical Morning Routine for Busy People Hosted on Acast. See acast.com/privacy for more information.

This week's episode is a masterclass on vascular anomaly treatment. Brush up on your malformations with Dr. Cliff Weiss, the Director of the Vascular Anomaly Center at Johns Hopkins. He shares next-level techniques, precision diagnostics, and his 'gold standard' approach to alcohol sclerotherapy.---This podcast is supported by:RADPAD® Radiation Protectionhttps://www.radpad.com/---SYNPOSISThe episode begins with the most vital component of patient care: establishing a correct diagnosis through proper classification. Dr. Weiss shares his philosophy that “MRI is a conversation” - not just an image, detailing the specific MRI protocols to confidently make a diagnosis over 90% of the time. He then shares an overview of the classification system, differentiating vascular tumors like hemangiomas from high-flow and low-flow vascular malformations.Dr. Weiss explores a wide array of treatment strategies tailored to each diagnosis. He walks through his techniques for treating low-flow malformations with sclerotherapy—using agents like alcohol, doxycycline, and bleomycin based on a lesion's location and characteristics—and his use of cryoablation for vascular tumors. He then dives into the creative and high-stakes approaches for treating AVMs, comparing transvenous and transarterial embolization with agents like Onyx and coils, before concluding with his predictions on the future of IR in the field.---TIMESTAMPS00:00 - Introduction 02:36 - Vascular Anomaly Center at Johns Hopkins06:33 - Vascular Anomaly & Malformation Diagnosis with Imaging09:04 - Classifying Vascular Anomalies15:55 - Vascular Tumors18:46 - Low-Flow Malformations27:58 - Needle Placement29:56 - Retro-orbital & ENT Malformations32:44 - AVM Treatment Strategy40:41 - Following up with Patients

Breast cancer awareness, early detection, mammograms, and modern treatment options—learn what women 40+ need to know now. In this Breast Cancer Awareness Month special, we talk breast cancer signs, risk factors, and how early detection saves lives. Dr. Elizabeth O'Leary—breast surgeon and head of Lady Slipper Breast Center—shares practical guidance on breast cancer screening, genetics, lifestyle, and survivorship. If you've delayed your mammogram, this conversation is your nudge. We cover what's changed in breast cancer care, what to ask your providers, and how to advocate for yourself with confidence.Timestamps(00:00) Introduction to Breast Cancer Awareness Month & why this episode matters(02:05) Meet Dr. Elizabeth O'Leary: training, Johns Hopkins, and founding Lady Slipper Breast Center(06:18) Patient-first care: time, personalization, and thriving after treatment(10:40) Lisa's breast cancer story: fear, surgery decisions, and believing for a cure(15:22) Early detection essentials: mammograms, dense breasts, and screening timelines(19:30) High-risk assessment at 25: who needs early imaging and why it matters(24:05) Genetics 101: family history, moving-target panels, and what results mean(28:48) Lifestyle factors: diet, exercise, stress, alcohol—what the research supports(34:12) Advocacy & self-trust: how to speak up and choose your care team(37:20) Hope & next steps: practical actions to take this week(39:15) Where to find Dr. O'Leary & Lady Slipper Breast CenterKey TakeawaysEarly detection saves lives. Annual mammograms (and MRI for select high-risk women) dramatically improve outcomes.High-risk assessment should start at 25. A formal risk review can identify women who need earlier or additional screening.Genetics is evolving. “Negative before” doesn't always mean negative now—panels and insights continue to expand.Lifestyle matters. Consistent movement, strength training, weight management, stress reduction, and limiting alcohol are linked to lower risk.You can be both calm and proactive. Ask questions, understand your options, and choose a team that treats the whole person.Guest BioDr. Elizabeth O'Leary, MD is a breast surgeon and founder of Lady Slipper Breast Center in Minnesota (St. Paul, St. Louis Park, Edina). Trained at the University of Minnesota and Johns Hopkins, she specializes in personalized, comprehensive breast care—from screening and diagnosis through treatment and survivorship—with a focus on early detection, minimally invasive approaches, and patient-centered outcomes.Resource LinksLady Slipper Breast Center (Dr. Elizabeth O'Leary): https://www.elizabetholearymd.comFind a high-risk breast clinic near you (search “breast cancer high risk clinic” + your city)Breast density info & screening options (ask your imaging center about tomosynthesis and MRI for high-risk patients)Lifestyle tools: activity trackers, strength programs for women 40+, and stress-reduction practices (breathwork, prayer, therapy)Tags/Keywordsbreast cancer awareness, breast cancer, early detection, mammogram,...

ABOUT THIS EPISODEDLL3 is emerging as a promising new target for neuroendocrine cancers. In this episode, Dr. Rohit Thummalapalli, medical oncologist at Memorial Sloan Kettering Cancer Center, explains what DLL3 is, how it works, who might benefit, and what current clinical trials are teaching us. He breaks down the science, treatment options, and future directions in a way that is clear, approachable, and designed to help patients and families better understand this developing area of care.TOP TEN QUESTIONS Understanding the Basics1. What is immunotherapy? How does immunotherapy work?2. What is DLL3? How does it work in the context of neuroendocrine cancer?3. How is DLL-targeted therapy similar to or different from other types of immunotherapy? Is there evidence that one works better than another?Indications, Use, Access & Availability4. When is DLL3 used in neuroendocrine cancers? What types of neuroendocrine cancer might express DLL3?How does someone know if this is a potential treatment option for them?At what point in a patient's treatment journey might DLL3 be considered?How and where DLL3 is available for neuroendocrine cancer patients? What are other ways, if any, to access DLL3?Testing for DLL3 Expression5. How does someone find out if their tumors express DLL3 receptors? How & where is DLL3 expression tested? It it tested through tissue samples, imaging, or something else?Is there a minimal level of DLL3 expression that is required to receive the treatment? (Does the threshold vary by trial?)Does the level of DLL3 expression differ by institution? Does the level of DLL3 expression predict how well someone might respond to treatment?Can the tumor expression of DLL3 vary from tumor to tumor? Can it vary over time, meaning can tumors gain or lose expression?Do you measure the DLL3 expression following treatment?Treatment Considerations6. How effective is DLL3-targeted therapy in neuroendocrine cancers? What is the goal of treatment with DLL3 – shrinkage, stabilization, symptom relief? How long is it expected to work? How do you measure the response to DLL3 treatment? 7. Can DLL3 be combined with other therapies? Decision-Making and Patient Counseling8. How do you decide when to offer DLL3 for someone with neuroendocrine cancer? What factors or prior treatments might make someone ineligible for DLL3 therapy?Could receiving DLL3 exclude a patient from other treatments or clinical trials?9. How do you counsel patients who are considering DLL3?  What should they know about how the treatment is given, possible side effects, and what's known (or unknown) about long-term safety?What should one expect in terms of frequency of visits, hospitalization and side effects?Can someone still work while receiving DLL3?Looking Ahead10. What are the key questions you hope to answer about DLL3 in the next year? What do you hope to learn over the next 3 to 5 years?ABOUT DR. ROHIT THUMMALAPALLI Rohit Thummalapalli is a gastrointestinal medical oncologist and assistant attending physician at Memorial Sloan Kettering Cancer Center specializing in clinical care and research in patients with neuroendocrine and biliary tract cancers. Originally from Florida, Dr. Thummalapalli completed medical training at Harvard and Johns Hopkins before arriving at MSK as a medical oncology fellow in 2021, and started on faculty in 2024.For more information, visit https://www.ncf.net/podcast/48For more information, visit NCF.net.

Never Make a Decision Based on Fear Today we discuss a listener email who is afraid to go to college after being present when Charlie Kirk was shot. Decisions should never be made based on fear. They should be made on logic and reason. We talk about ways to cope with the emotions that come with seeing or experiencing a traumatic event. We cover looking at both sides of a situation and doing a cost-benefit analysis. We also talk about the 2019 study from Johns Hopkins about how Tylenol can increase the risk of Autism and ADHD for the child. The big lesson today is to Question Everything, especially what we "know" to be true. Sponsors: American Gold Exchange Our dealer for precious metals & the exclusive dealer of Real Power Family silver rounds (which we finally got in!!!). Get your first, or next bullion order from American Gold Exchange like we do. Tell them the Real Power Family sent you! Click on this link to get a FREE Starters Guide. Or Click Here to order our new Real Power Family silver rounds. 1 Troy Oz 99.99% Fine Silver Abolish Property Taxes in Ohio: www.AxOHTax.com  Get more information about abolishing all property taxes in Ohio. Our Links: www.RealPowerFamily.com Info@ClearSkyTrainer.com 833-Be-Do-Have (833-233-6428)

Breast Cancer Awareness Month reminds us: early detection saves lives.

Hantao Yuan is Co-Founder of Moku, and serves as Moku's marketing growth chief and community strategist. He has been acquiring creators and users for over a decade for game publishers and gaming brands. He has also sold his own esports team through M&A to Overtime sports, and advised 2 other teams through M&A.Moku is backed by a world-class team of AI experts from MIT, IBM, and Johns Hopkins. The company has already built Web3's largest distribution engine, driving over 8 million daily active users across partner launches and more than $7 billion in cumulative fully diluted value (FDV). With this foundation, Moku is uniquely positioned to expand Grand Arena beyond Web3 and into mainstream fantasy sports and interactive wagering markets. Grand Arena is converging the $27B fantasy sports market, the $40B prediction market, and the $50B+ AI gaming sector.In this conversation, we discuss:- Letting users speculate on gaming- AI content is getting out of control - Speculation + daily fantasy + AI - Betting on live matches - Current state of Web3 Gaming - Bridging Web2 & Web3 audiences - Speculation is the future of entertainment - Why Prediction Markets will work - Hantao selling his own esports to Overtime sports - The history of Moku Moku X: @Moku_HQDiscord: discord.gg/mokuYouTube: @MokuHQHantao YuanX: @HantaoLinkedIn: Hantao Yuan---------------------------------------------------------------------------------This episode is brought to you by PrimeXBT.PrimeXBT offers a robust trading system for both beginners and professional traders that demand highly reliable market data and performance. Traders of all experience levels can easily design and customize layouts and widgets to best fit their trading style. PrimeXBT is always offering innovative products and professional trading conditions to all customers.  PrimeXBT is running an exclusive promotion for listeners of the podcast. After making your first deposit, 50% of that first deposit will be credited to your account as a bonus that can be used as additional collateral to open positions. Code: CRYPTONEWS50 This promotion is available for a month after activation. Click the link below: PrimeXBT x CRYPTONEWS50

Subscribe now for the full episode. Don't forget to vote for AP in the 2025 Signal Awards! Derek welcomes back to the show Esfandyar Batmanghelidj, founder of the Bourse & Bazaar Foundation and professor at Johns Hopkins, to talk through the slow demise of the Iran nuclear deal. They delve into Europe's decision to trigger the UN “snapback” mechanism, factors that lead to this moment, from Trump's withdrawal and Biden's hesitation to Europe's impatience and Iran's deepening ties with Russia and China, the effects of sanctions being imposed without diplomacy, and why the JCPOA's collapse is a symptom of a wider breakdown in the international order. Learn more about your ad choices. Visit megaphone.fm/adchoices

In his weekly clinical update, Dr. Griffin with Vincent Racaniello chat about the ongoing Ebola outbreak in DRC, increases in screwworm diagnoses, a pertussis death in Mississippi before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, monoclonal antibody therapy against RSV, where to find PEMGARDA, long COVID treatment center, where to go for answers to your long COVID questions, olfactory dysfunction following SARS-CoV-2 infection and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Ebola Disease (WHO: African Region) Mexico sees 32% jump in flesh-eating screwworm cases since August as cases move north (Reuters) Pediatric Pertussis Death Reported (Mississippi State Department of Health) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Measles (CDC: Measles Rubeola) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) Influenza-Associated Pediatric Deaths — United States, 2024–25 Influenza Season (CDC: MMWR) ACIP Recommendations Summary (CDC: Influenza) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season (JAMA: Open Network) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines (Cochrane Library) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort (JAMA: Open Network) Reaching out to US house representative Letters read on TWiV 1258 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of the NCS Podcast Hot Topics series, host Dr. Nicholas Morris speaks with Dr. Wendy Ziai, professor of neurology at Johns Hopkins and senior editor for Neurocritical Care, and Dr. Richard Choi, neurointensivist at MedStar Franklin Square and social media editor for the journal. This episode also introduces Dr. Richard Choi as the new host of the NCS Podcast Hot Topics series, which will continue to feature high-impact articles from Neurocritical Care. They discuss a new study, Postoperative Monitoring After Elective Intracranial Surgery in a Postanesthesia Care Unit is Safe, Efficient and Cost-Effective, by Arthur Wagner and colleagues in Munich, Germany. The conversation examines the 10-year experience with more than 5,500 patients, complication rates and how PACU-based pathways may ease ICU demand while supporting safe outcomes. Dr. Ziai and Dr. Choi also share perspectives on ICU capacity and the importance of collaboration across departments, showing how this research connects to real-world practice. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

About this episode: Social media and AI chatbots are changing the landscape of suicide prevention, requiring a multidisciplinary care model. In this episode: Walker Tisdale, Johns Hopkins' Director of Outreach for Suicide Prevention Initiatives, discusses how these developing technologies are changing care models and how to help loved ones who are struggling with suicidal thoughts. Guest: Walker R. Tisdale III, MPH, DSW, is a leading subject-matter expert and national speaker on suicide prevention, crisis intervention, health equity and the social determinants of health. He serves as the Director of Outreach for Suicide Prevention Initiatives at Johns Hopkins University. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: What My Daughter Told ChatGPT Before She Took Her Life—New York Times September is National Suicide Prevention Month—The Hub Behavioral Health Crisis Support Team—Johns Hopkins University Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Send us a textAbout Maria Pribis, OD, FAAO, Diplomate of the American Board of optometry from the University of Pittsburgh where she was a member of the dance team. She then graduated with high honors from Pennsylvania College of Optometry at Salus University. While in optometry school she was president of SOSH. Dr. Pribis was inducted into BSK honor society. She completed an ocular disease residency at the Baltimore VA Hospital. During this time she rotated through Johns Hopkins cornea and specialty contact lens clinics. She's been a partner in private practice in Stamford, CT since 2010. She specializes in ocular surface disease and contact lenses and has a special interest in myopia control. Dr. Pribis lectures extensively with the optometry education company, KMK. Dr. Pribis was awarded Connecticut's young optometrist of the year award in early 2015. She is the founder of Ocularprime, which is a website that encourages you to “Live in Your OcularPrime,” which is a short phrase designed to support a commitment to consistency across the entire health spectrum for those who want to become the best version of themselves. In her free time she enjoys spending time with her husband and daughter. 

This week’s episode of Pathology with Dr. Priya, a Zone 7 series, is all about your questions on the science behind death investigation. Together, Sheryl McCollum and Dr. Priya Banerjee take on the topics that listeners are most curious about, from family rights and religious objections to what autopsies can and cannot reveal. They also dispel misconceptions about embalming, toxicology, and even what really happens at the funeral home. With clarity and respect, Dr. Priya and Sheryl break down the science, the law, and the realities behind the most-asked questions in forensic pathology. Highlights (0:00) Welcome to Pathology with Dr. Priya: A Zone 7 series—Sheryl and Dr. Priya open with a discussion of the Celeste Rivas case (6:45) The "CSI-effect": how media shapes public perception of forensic science, the risks of misinformation, and why caution is critical in cold case investigations (8:45) Can a forensic pathologist always determine the cause and time of death? (11:15) Can family members refuse an autopsy, and how do religious objections work? (17:00) Can any family member request a private autopsy, or must it be the legal next of kin? (19:00) Does an autopsy prevent an open-casket funeral? (21:15) Do funeral homes use newspapers or sawdust to fill body cavities? (23:15) Can an autopsy be performed after embalming, and how does that affect toxicology? (25:30) The role of funeral directors and double-checks before cremation, catching missed injuries and ensuring nothing is overlooked About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, NSA cases, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.comTwitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.comTwitter/X: @ColdCaseTipsFacebook: @sheryl.mccollumInstagram: @officialzone7podcast

Send us a textWhat if cancer could be detected years before symptoms ever appear? In this episode of Causes or Cures, Dr. Eeks sits down with Dr. Yuxuan Wang, cancer researcher at Johns Hopkins, to discuss her team's promising work on multicancer early detection (MCED) blood tests.These ultra-sensitive sequencing tests can spot tiny fragments of tumor DNA circulating in the blood. In their recent study, the MCED test flagged early cancer signs in 8 out of 26 participants who were later diagnosed — half of them more than three years before their cancer was picked up clinically. While still experimental and not FDA-approved, this research points to a future where cancer screening might extend well beyond mammograms and colonoscopies.In this episode, we cover:Dr. Wang's journey into cancer research and what inspired her focus.What multicancer early detection (MCED) blood tests are and how they work.How the Johns Hopkins study was designed and what the key results showed.Which cancer types were detected and what limitations still exist.Challenges such as false positives, incidental findings, and overtreatment risks.The ethical and practical questions of telling patients they may have cancer years before symptoms.Cost and accessibility concerns: how to make such tests affordable if approved.Next steps toward larger trials, FDA approval, and clinical use.How MCED could change the landscape of cancer screening and prevention in the future.Balancing public enthusiasm, media attention, and scientific caution.This is a fascinating and nuanced conversation about the possibilities, and challenges, of catching cancer earlier than ever before.You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here! (Now featuring interviews with top experts on health you care about!)Support the show

The dangerous intersection of inflammatory rhetoric and real-world violence takes center stage in this urgent analysis of America's deepening political divide. We examine the recent shooting at a Dallas ICE facility that left two migrants dead, where the FBI quickly identified an ideological motive with shell casings marked "anti-ICE." Yet mainstream media continues to obscure these clear motivations, creating a dangerous environment where accountability becomes impossible and violence continues unchecked.As political figures adopt increasingly extreme language—from Gavin Newsom demanding ICE agents "unmask" to New Mexico Senator Joe Cervantes comparing ICE to the KKK—we're witnessing leadership that validates rather than calms extremist viewpoints. This pattern repeats across virtually every issue facing Americans today.Drawing from personal experience as parents of a child with autism, we dive into the Trump administration's announcement of research linking prenatal Tylenol use to autism. Despite being backed by studies from Harvard and Johns Hopkins, this potentially groundbreaking information was immediately framed as "misinformation" by political opponents, demonstrating how tribal politics now trumps scientific inquiry and public health.The politicization extends to healthcare access in New Mexico, where bipartisan efforts to address doctor shortages through interstate medical compacts are being blocked by powerful trial lawyers in the state senate. Even Google has admitted to censoring Americans at the Biden administration's request regarding COVID-19 information that has since been proven accurate.What makes this episode particularly compelling is how it connects these seemingly disparate issues to reveal a fundamental breakdown in American discourse. When politics infects every aspect of life—from medical research to basic healthcare access—citizens suffer while special interests thrive. Join us as we cut through the noise and examine how we might begin healing this dangerous divide.Rate, review and subscribe to help spread the word, or visit NoDoubtAboutItPodcast.com to support our work directly.Website: https://www.nodoubtaboutitpodcast.com/Twitter: @nodoubtpodcastFacebook: https://www.facebook.com/NoDoubtAboutItPod/Instagram: https://www.instagram.com/markronchettinm/?igshid=NTc4MTIwNjQ2YQ%3D%3D

Amy and T.J. did a deep dive on the recent and conflicting research on whether acetaminophen- the active ingredient in Tylenol - has a proven link to an increased risk of Autism. From some of the most respected scientific minds - we’re talking Harvard, Johns Hopkins and JAMA - there is no simple explanation, so why are Trump and RFK Jr claiming they have the answer? See omnystudio.com/listener for privacy information.

Amy and T.J. did a deep dive on the recent and conflicting research on whether acetaminophen- the active ingredient in Tylenol - has a proven link to an increased risk of Autism. From some of the most respected scientific minds - we’re talking Harvard, Johns Hopkins and JAMA - there is no simple explanation, so why are Trump and RFK Jr claiming they have the answer? See omnystudio.com/listener for privacy information.

Amy and T.J. did a deep dive on the recent and conflicting research on whether acetaminophen- the active ingredient in Tylenol - has a proven link to an increased risk of Autism. From some of the most respected scientific minds - we’re talking Harvard, Johns Hopkins and JAMA - there is no simple explanation, so why are Trump and RFK Jr claiming they have the answer? See omnystudio.com/listener for privacy information.

This week on Pathology with Dr. Priya, a Zone 7 series, Dr. Priya Banerjee and Sheryl McCollum walk through a case that’s captured national attention—the discovery of a missing teenager’s body in the trunk of a car linked to a rising music star. From decomposition and dismemberment, to teeth, tattoos, and tech, Dr. Priya breaks down how identification works when the body is severely compromised. Together, she and Sheryl discuss the forensic challenges, legal red flags, and the many unanswered questions that still surround the case. Highlights (0:00) Sheryl McCollum and Dr. Priya focus the week’s episode on the discovery of a young girl's body in the trunk of a famous musician’s car (4:45) How decomposition and dismemberment alter a body, and the tools pathologists use to uncover the truth (11:00) Tattoos, teeth, and tech come into play as investigators work to identify the victim and interpret the meaning behind the song “Romantic Homicide” (15:30) Dating a minor: red flags, blurred boundaries, and the legal realities behind grooming and consent (16:45) “I got a beater car, and if it ain’t in my driveway, I’m going to call somebody.” Why the car wasn't reported stolen and what that might suggest about ownership and intent (17:45) How anthropology and toxicology provide answers when traditional autopsy results fall short (24:30) Looking at the bigger picture: survival, exploitation, and the forensic clues left behind in both bones and behaviors About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, NSA cases, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.comTwitter/X: @Autopsy_MD Sheryl McCollum is an Emmy Award–winning CSI, a writer for CrimeOnline, and the Forensic and Crime Scene Expert for Crime Stories with Nancy Grace. She works as a CSI for a metro Atlanta Police Department and is the co-author of the textbook Cold Case: Pathways to Justice. Sheryl is also the founder and director of the Cold Case Investigative Research Institute (CCIRI), a nationally recognized nonprofit that brings together universities, law enforcement, and experts to help solve unsolved homicides, missing persons cases, and kidnappings. Email: coldcase2004@gmail.comTwitter/X: @149zone7Facebook: @sheryl.mccollumInstagram: @officialzone7podcast

Dr. John Gartner, former Johns Hopkins professor and co-host of the podcast ‘Shrinking Trump,' joins the Beast's Joanna Coles to deliver a chilling diagnosis: Donald Trump is showing signs of dementia layered on top of malignant narcissism. Drawing on decades of clinical expertise, Dr. Gartner explains how Trump's declining language, erratic gait, and disturbing anecdotes point to brain deterioration that makes him not just unpredictable but uniquely dangerous in office. Coles presses him on how Trump's narcissism compares to King Charles' public persona, whether his cabinet and family are retreating from his volatility, and what it means when a leader with nuclear codes also displays symptoms of mini-strokes and confabulation. From Hitler's psychology to Bill Clinton's benign narcissism, this episode explores how power amplifies paranoia, cruelty, and decay—and asks the starkest question of all: as Trump weakens physically and mentally while tightening his grip on authority, how far can Trumpism go before it breaks America? Hosted on Acast. See acast.com/privacy for more information.

Jimmy Kimmel's late-night show has been pulled off the air following his comments about Charlie Kirk's killer. On this week's On the Media, how threats to free speech have escalated in the wake of the assassination. Plus, a school librarian in Louisiana shares how she's been targeted by book-banning activists.[02:25]  Host Micah Loewinger sits down with Lily Mason, professor of political science at Johns Hopkins and the co-author of the book Radical American Partisanship: Mapping Violent Hostility, to discuss what data we have on how Americans think about political violence. [21:07] Micah speaks with Ryan Broderick, author of the Garbage Day newsletter, to examine the evidence around Charlie Kirk's alleged killer, and what radicalization looks like in a digital age.  [35:45] Host Brooke Gladstone talks with Amanda Jones, school librarian in Livingston Parish, Louisiana and former School Librarian of the Year, to discuss being a target of book-banning activists. Plus, why protecting libraries is as crucial as ever. Further reading / listening:Radical American Partisanship: Mapping Violent Hostility, Its Causes, and the Consequences for Democracy, by Lily Mason“Charlie Kirk was killed by a meme,” by Ryan BroderickThat Librarian: The Fight Against Book Banning in America, by Amanda Jones On the Media is supported by listeners like you. Support OTM by donating today (https://pledge.wnyc.org/support/otm). Follow our show on Instagram, Twitter and Facebook @onthemedia, and share your thoughts with us by emailing onthemedia@wnyc.org.

Dr. Diane Hennacy is a Johns Hopkins-trained neuropsychiatrist, author, public speaker, and independent researcher exploring the intersection of science, consciousness, and anomalous phenomena like telepathy and psychic abilities. With over 30 years of clinical experience, she has served on the faculty at Harvard Medical School and participated in think tanks on human consciousness at the Salk Institute. Hennacy's groundbreaking work bridges rigorous scientific inquiry with mysteries of the mind, including studies on autism, savant syndrome, and potential links to extrasensory perception (ESP). Her bestselling book, The ESP Enigma: The Scientific Case for Psychic Phenomena (2009), presents evidence from neuroscience, quantum physics, and case studies to explain psychic experiences. A student of ancient wisdom traditions and an award-winning clinician, she has spoken at international scientific conferences, the United Nations, and venues like TEDx, advocating for open-minded exploration of human potential and consciousness. Hennacy, who also held the title of Miss Oregon Senior America 2017, continues her research through the Hennacy Institute for Consciousness Research, emphasizing integrative medicine and the evolution of human awareness. Shawn Ryan Show Sponsors: https://americanfinancing.net/srs NMLS 182334, nmlsconsumeraccess.org. APR for rates in the 5s start at 6.327% for well qualified borrowers. Call 866-781-8900, for details about credit costs and terms. https://tryarmra.com/srs https://aura.com/srs https://betterhelp.com/srs This episode is sponsored. Give online therapy a try at betterhelp.com/srs and get on your way to being your best self. https://bubsnaturals.com – USE CODE SHAWN https://shawnlikesgold.com https://mypatriotsupply.com/srs https://patriotmobile.com/srs https://ROKA.com – USE CODE SRS https://shopify.com/srs https://trueclassic.com/srs https://USCCA.com/srs Dr. Diane Hennacy Links: Website - https://drdianehennacy.com X - https://x.com/drhennacy41125 Buy The ESP Enigma - https://drdianehennacy.com/purchase-esp-enigma Learn more about your ad choices. Visit podcastchoices.com/adchoices